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Abstract—Persons with spinal cord injury (SCI) have height-
ened risk for cardiovascular disease (CVD). Multidisciplinary 
risk reduction programs using case management models have 
been effective in reducing CVD risk in nondisabled persons, 
but little is known regarding the effects of such programs in 
SCI. Twenty-six persons with SCI underwent a pilot 2 yr risk 
intervention program including frequent telephone contact by a 
case manager and in-person visits by a dietitian, physical thera-
pist, and exercise physiologist. At 6 mo intervals, measure-
ments were made of dietary intake, glucose and lipids, physical 
activity patterns, and exercise capacity. Of the 26 participants, 
10 remained in the program for the full 2 yr; medical issues 
unrelated to the program were the major reasons for dropping 
out. Significant improvements were observed in weight, 
plasma insulin, homeostatic model assessment insulin resis-
tance, and total cholesterol/high-density lipoprotein ratio, 
although these changes were not consistent across visits. No 
differences in estimates of physical activity patterns were dem-
onstrated, nor were differences in dietary macronutrient intake 
observed. Thus, modest changes in some CVD risk markers 
can be achieved by a multidisciplinary risk reduction program 
in SCI. Such programs present more challenges than in ambu-
latory persons, and more intensive risk intervention may be 
required to appreciably reduce CVD risk in SCI.
Key words: case management, diabetes, diet, exercise testing, 
heart disease, insulin resistance, obesity, paraplegia, physical 
activity, spinal cord injury.
INTRODUCTION
Historically, respiratory and renal conditions have 
been the most common causes of mortality in the spinal 
cord injury (SCI) population [1–3]. However, as the life 
span in persons with SCI has lengthened, a greater fre-
quency of aging-related conditions has evolved [1,4]. In 
particular, data published in recent years suggest that car-
diovascular disease (CVD) has become a highly prevalent 
cause of mortality in SCI. Morbidity from cardiovascular 
causes, particularly coronary artery disease (CAD), is 
high relative to the general population, and CAD tends to 
occur earlier in individuals with SCI than among ambula-
tory persons [3–6]. A major contributor to the heightened 
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risk of CVD after SCI is the fact that metabolic risks, 
including hyperlipidemia, obesity, and diabetes, have 
been shown to be particularly common among these indi-
viduals [3,6–11]. Recognition and intervention for CVD 
risk is an emerging clinical challenge in this population.
An additional contributing factor to the high cardio-
vascular morbidity and mortality in SCI is the sedentary 
lifestyle and reduced physical function associated with 
loss of motor function [3,12–14]. Participation in physi-
cal activity for persons with SCI is limited not only by 
the obvious physical barriers but also by limited avail-
ability of facilities and transportation, as well as psycho-
social barriers. Additional impediments to physical 
activity may include social isolation, low motivation, low 
self-esteem or even depression, and poor body image 
[15–16]. While it is well known that greater physical 
activity confers significant benefits on health and longev-
ity in ambulatory individuals, whether it confers the same 
level of benefit in persons with SCI has not been ade-
quately explored. Roughly two-thirds of Americans do 
not meet the minimal recommendations for physical 
activity, and it has been suggested that this number is in 
the range of 80 to 90 percent in persons with SCI [9,17]. 
Therefore, because of these physical and psychosocial 
barriers, few individuals with SCI achieve the benefits of 
physical activity available to ambulatory persons. These 
impediments to physical activity no doubt further con-
tribute to heightened CVD risk in SCI [3,9–16].
Nutrition and energy balance among persons with 
SCI have also been widely studied in recent years. Rest-
ing metabolic rates are comparatively low in SCI, and 
total energy expenditure has been reported to be approxi-
mately 20 percent lower in individuals with paraplegia 
than in ambulatory persons [18–19]. Dietary patterns 
have been shown to be generally poor in persons with 
SCI; much like the general U.S. population, dietary 
intakes in persons with SCI tend to be high in fat, low in 
complex carbohydrates, low in fiber, and lacking in par-
ticular micronutrients [20–21]. These issues have been 
suggested to underlie higher rates of obesity, abnormal 
lipid profiles, and insulin resistance in persons with SCI 
[19]. While efforts have been made to study the effects of 
dietary modification on atherogenic risk in SCI [22], there 
is a paucity of data available regarding dietary reference 
standards for persons with SCI. A 2009 American 
Dietetic Association evidence-based practice guideline on 
nutritional needs for SCI emphasized the need for nutri-
tional intervention in order to improve the nutritional sta-
tus and weight management of persons with SCI [23].
A need exists to explore models designed to reduce 
CVD risk in persons with SCI. Case management meth-
ods, which emphasize a multidisciplinary team approach 
and numerous patient contacts, have been shown to be 
effective in modifying risk and reducing mortality among 
ambulatory persons with CVD [24]. In fact, such pro-
grams have been incorporated into treatment guidelines 
for patients with chronic heart failure and post-myocardial 
infarction patients referred for cardiac rehabilitation [25–
26]. However, little is known regarding such programs 
among individuals following SCI. Moderate success has 
been achieved using targeted programs for weight loss 
[27], lipid modification [28], and physical activity partici-
pation [29], but few data are available on comprehensive, 
multidisciplinary approaches to reduce cardiac risk after 
SCI. Using methods similar to those that have been suc-
cessful among ambulatory post-myocardial infarction sub-
jects [24], we employed a case-managed approach in an 
effort to reduce CVD risk in a group of patients followed 
at our SCI Center. The program, termed Customized 
Health Assessment and Risk Management, was a pilot 
study that sought to determine the influence of a multidis-
ciplinary risk management program on CVD risk in per-
sons with SCI over a 2 yr period.
METHODS
Participants and Recruitment
We recruited 26 male patients with SCI (mean ± stan-
dard deviation [SD] age 57 ± 6 yr) at high risk for CVD 
from the Department of Veterans Affairs (VA) Palo Alto 
Health Care System (VAPAHCS) SCI Center. Of the 26 
participants, 10 had a cervical, 13 a thoracic, and 3 a lum-
bar level of injury. All SCI subjects were nonambulatory. 
American Spinal Injury Association Classification and 
other clinical, risk factor, and demographic characteristics 
of the participants are presented in Table 1. CVD risk was 
determined by calculating the Framingham Risk Score 
(FRS) [30] initially from information in the electronic 
medical record and confirmed during screening. Only per-
sons with an FRS associated with an age-adjusted 20 per-
cent or greater 10 yr absolute risk of CVD, but no overt 
CVD, were considered eligible for inclusion. Of the 
approximately 800 veterans served at our SCI Center 
annually, we estimate that about 50 percent would meet Characteristic Value
Age, Current (yr), mean ± SD (range) 56.92 ± 5.74 (45–69)
Height (in.), mean ± SD (range) 70.75 ± 2.52 (66–76)
Weight (lb), mean ± SD (range) 213.29 ± 38.6 (155–288)
BMI (kg/m2), mean ± SD (range) 29.87 ± 5.16 (22.6–40.2)
Time Since Injury (yr), mean ± SD (range) 23.8 ± 12.3 (2–50)
Risk Factors, No. (%)
4 (15.4)
2 (7.7)
19 (73.1)
6 (23.1)
10 (38.5)
11 (42.3)
Level of Injury, No.
10
13
3
ASIA Classification, No. (%)
9 (34.6)
0
8 (30.8)
4 (15.4)
5 (19.2)
1357
MYERS et al. Cardiovascular risk reduction in SCI
this criterion. At baseline, a complete cardiovascular 
examination was performed. Historical and current infor-
mation on tobacco use, blood lipids, body mass index 
(BMI), hypertension, physical activity patterns, blood 
glucose, and other risk information was obtained.
Study Design
This study was a pilot evaluation, with each subject 
as his own control. After recruitment and initial testing, 
participants underwent a baseline visit that included 
blood analyses; dietary, lifestyle, and physical activity 
questionnaires; a maximal exercise test; an evaluation by 
a physical therapist; and recommendations for individu-
alized exercise and nutrition plans. Using a case manage-
ment model [31], participants were then contacted by 
phone weekly during the first 6 weeks, then again at 8 wk 
and at 3, 4, 5, and 6 mo. This was followed by complete 
evaluations in the SCI Center at 12, 18, and 24 mo, dur-
ing which all the baseline measurements were repeated.
Measures of Cardiac Risk
A full blood lipid profile, including total cholesterol, 
high-density lipoprotein (HDL), low-density lipoprotein, 
and triglycerides, along with homocysteine, high sensitiv-
ity C-reactive protein, fasting glucose, insulin and the 
homeostasis model of assessment-insulin resistance 
(HOMA-IR) were determined at each study visit. All blood 
samples were drawn and processed at the VAPAHCS labo-
ratory using standardized techniques. Body dimensions 
were expressed as BMI (weight in kilograms divided by 
height in meters squared) determined from direct weighing 
on a scale (wheelchair with participant minus wheelchair 
alone) and self-reported height. Resting blood pressure was 
averaged from two separate measurements after the partici-
pant rested in the supine position for a minimum of 10 min. 
Five participants were included who had a current diagno-
sis of type 2 diabetes; there were no type 1 diabetics, and 
all had fasting glucose levels controlled pharmacologically.
Exercise Testing
Exercise testing was performed using individualized 
tests in our SCI exercise research laboratory. Standard 
pulmonary function tests were performed prior to the 
exercise test, with measures of forced vital capacity 
(FVC), forced expiratory volume in 1 s (FEV1), and peak 
expiratory flow obtained and expressed as a percentage of 
normal using American Thoracic Society Standards [32]. 
Maximal exercise testing was performed using an elec-
tronically braked arm ergometer in the upright seated 
position with the wheelchair secured. Study participants 
were requested to maintain the arm crank cadence at 
60   rpm throughout the test. Changes in resistance of the 
arm ergometer were individualized such that the test dura-
tion ranged from 8 to 12 min, and the same ramp rate was 
used for a given person for each test throughout the fol-
low-up period. A standard 12-lead electrocardiogram and 
ventilatory gas exchange data were obtained throughout 
the exercise test and recovery period. Perceived exertion 
was recorded each minute using the Borg 6–20 scale [33]. 
All participants were encouraged to give a maximal effort; 
tests were terminated when volitional fatigue occurred, 
when the participant was no longer able to maintain a 
cadence of 60 rpm, or both.
Activity Monitoring
Activity status was quantified using the Physical 
Activity Scale for Individuals with Physical Disabilities 
(PASIPD) [34], the VA Physical Activity Questionnaire 
modified for SCI (VAPAQSCI), and the intermittent use of 
an accelerometer. The PASIPD is a 13-item scale 
designed to provide information on leisure, household, 
Table 1.
Clinical and demographic characteristics of participants at entry (N = 26).
    Smoking (past or current)
    Hypertension
    Hyperlipidemia
    Type 2 Diabetes
    Overweight (BMI 25–30 kg/m2)
    Obesity (BMI > 30 kg/m2)
    Cervical
    Thoracic
    Lumbar
    Tetraplegia, ASIA A & B
    Tetraplegia, ASIA C
    Paraplegia, ASIA A & B
    Paraplegia, ASIA C
    All ASIA D
ASIA = American Spinal Injury Association, BMI = body mass index, SD = 
standard deviation.1358
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and occupational activities. A PASIPD composite physi-
cal activity score was derived and expressed as metabolic 
equivalent (MET)-hours/day. The VAPAQSCI entails an 
interview in which subjects describe detailed daily recrea-
tional and occupational activities. The VAPAQ has been 
extensively used in epidemiologic studies to quantify 
activity patterns among ambulatory persons expressed in 
kilocalories per day [35]. In our modified version 
(VAPAQSCI), energy costs of activities were based on 
those developed by Collins et al. [36] for persons with 
SCI. To obtain objective measures of activity, an acceler-
ometer (ActiGraph model GT1M; Pensacola, Florida) 
was used for 3 d periods at the time of each study visit. 
The accelerometer is a small (3.8 × 3.7 × 1.5 cm) light-
weight (42.6 g) uniaxial device attached to the dominant 
wrist that measures acceleration in the vertical plane. The 
device contains a piezoelectric sensor that generates a 
voltage signal in proportion to acceleration caused by ten-
sion-induced deformation of the sensor. It was initialized 
to collect data in 1 s epochs, and the results were down-
loaded directly to a computer using a USB cable. The 
algorithm described by Crouter et al. [37] was used to 
convert accelerometry data (counts) into METs, and kilo-
calories per minute were determined using kcals/min = 
(METs × 3.5 × body weight in kg)/200.
Dietary Intake
Dietary intake was quantified using the Block food 
frequency questionnaire [38]. Participants were asked to 
record dietary intake in accordance with a random sched-
ule during a 3 d period, including one weekend day. 
Nutrient analysis of the diet was recorded throughout, 
including total calorie intake, intake of macronutrients 
(fat, protein, carbohydrates), percent calories from fat, 
percent calories from saturated fat, polyunsaturated to 
saturated fat ratio, fiber, and cholesterol intake.
Risk Management Intervention and Monitoring
The risk management program was physician-
supervised but managed by nonphysician health profes-
sionals. During an initial visit, measurements were 
obtained as described previously, and patients received 
both verbal and written educational materials specific to 
their individual risk factors. A schedule was established 
for subsequent telephone contacts and clinic visits. Nutri-
tional counseling, smoking intervention, and lipid-
lowering therapy were provided individually to meet thera-
peutic goals. Participants were triaged to the VAPAHCS 
Smoking Cessation, Diabetes, and Lipid Management 
Clinics as appropriate. Interventions were evidence-based, 
using current consensus statements as guidelines for both 
treatment and therapeutic goals. Appropriate treatments 
were tailored to meet consensus statement guidelines, 
including the National Institutes of Health (NIH) National 
Cholesterol Educational Program, the Centers for Disease 
Control/American College of Sports Medicine recommen-
dations for physical activity, the American Heart Associa-
tion Dietary Guidelines, and the NIH Consensus Statement 
on Detection and Treatment of High Blood Pressure [30]. 
Maximal exercise tests at each visit were coupled with a 
counseling session with a physical therapist to review the 
individual’s activity capabilities and provide activity rec-
ommendations. During each of the visits, pharmacologic 
therapy was revised as needed and additional assistance 
with diet, exercise, or smoking cessation was provided on 
an individualized basis in order to optimize both treatment 
of risk factors and compliance with dietary and lifestyle 
recommendations.
Analysis
Data are presented as mean ± SD. All measurements 
were compared to baseline at each measurement interval, 
initially using t-tests for paired observations. Because the 
number of comparisons changed at each measurement 
point and the data were not normally distributed, bino-
mial sign tests were used to explore whether differences 
existed in medians between the distributions of each vari-
able at each evaluation. This permitted an evaluation of 
the ratio of the number of participants who improved ver-
sus those who worsened at each evaluation. The latter 
comparisons are reported in the tables. The strength of 
the changes in the various risk markers was assessed by 
calculation of effect size.
RESULTS
At baseline, the sample included 73 percent with 
hyperlipidemia, 15 percent past or current smokers, 
23   percent diabetics, and 81 percent overweight or obese 
(Table 1). From the original sample of 26 persons 
enrolled, 22, 18, 15, and 10 completed 6 mo, 12 mo, 
18   mo, and 24 mo, respectively. Medical issues were the 
main reason for dropping out, followed by personal rea-
sons, inability to comply, travel issues, and inability to 
commit the time necessary to continue. Medical reasons 1359
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for dropping out included pressure sores (2 cases), back 
pain (2 cases), hand surgery (1 case), and uncontrolled 
dyslipidemia (1 case). Two participants died between the 
12 and 18 mo evaluations, both from multiple organ sys-
tem failure unrelated to the study.
Intervention effects on key risk markers at each mea-
surement point are presented in Table 2. Weight was 
reduced slightly at each follow-up point, but was signifi-
cantly lower only for the comparison between baseline 
and 6 mo (4 lb, p = 0.004). Fasting glucose did not 
change significantly, but mean values for both insulin and 
HOMA-IR were significantly lower at each comparison 
than at baseline. Reductions in insulin and HOMA-IR 
were confirmed by sign tests at the 6 and 12 mo evalua-
tions, in which 90 and 94 percent of participants exhibited 
reductions in insulin level, and 85 and 88 percent of sub-
jects exhibited reductions in HOMA-IR at 6 and 12 mo, 
respectively (p < 0.01 for all). Among lipid profiles, total 
cholesterol/HDL ratio was lower at the 6 mo evaluation 
(p = 0.05) and triglycerides tended to be lower at each 
evaluation (10%–20%). Total cholesterol was 3 to 7 per-
cent lower at each evaluation, but none of these compari-
sons reached statistical significance. Calculation of effect 
sizes indicated a strong effect only for insulin and 
HOMA-IR (effect sizes 0.80–0.90 at each evaluation 
point). Effect sizes for weight and lipid measures were 
generally <0.20, suggesting that the size of the effect was 
small.
Exercise test responses, physical activity parameters, 
and macronutrient intakes at each evaluation point are 
presented in Table 3. FEV1 was significantly higher at 
18   mo, and all but one subject increased FVC at this 
point (p = 0.07); however, these indices did not differ at 
other evaluations. No other exercise test variables dif-
fered between matching evaluation points. No differ-
ences were observed in objective or subjective estimates 
of physical activity patterns at any of the measurement 
intervals. No significant differences were observed in 
total calories, percentage of fat, carbohydrates, protein, 
or macronutrient intake at each matched comparison. 
However, the average total calories consumed at each of 
the time points was considerably lower than the average 
caloric intake observed in the U.S. general population 
(approximately 2,400 calories) as reported in the 
National Health and Nutrition Examination Survey III 
data [39]. In addition, caloric and macronutrient intakes 
were generally below the recommended Dietary Refer-
ence Intake standards for a comparable age/sex group.
DISCUSSION
The Healthy People 2020 report [40] and a 2009 
National Council on Disability report entitled “The current 
state of health care for persons with disabilities” [17] 
emphasized the role of cardiovascular risk assessment and 
management in adults with chronic SCI and included objec-
tives directed toward reducing barriers to participation in 
physical activity in persons with disabilities. Clearly, there 
has been a recent appreciation for the importance of modi-
fying CVD risk after SCI [3,10–12,14,17,41]. While 
previous efforts at comprehensive risk reduction have been 
successful in ambulatory persons using metrics that include 
lipid profiles, body dimensions, and even angiographic 
CAD [27–28,41], such programs in persons with SCI are 
more challenging. Barriers to effective risk reduction in SCI 
include lack of
Variable
6 Months (n = 22) 12 Months (n = 18) 18 Months (n = 15) 24 Months (n = 10)
Baseline Follow-Up p-Value Baseline Follow-Up p-Value Baseline Follow-Up p-Value Baseline Follow-Up p-Value
Weight 210.5 ± 38.0 206.7 ± 34.0 0.004 210.9 ± 35.0 207.1 ± 38.0 0.48 204.5 ± 36.0 200.8 ± 36.0 0.58 220.5 ± 40.0 219.5 ± 5.01 >0.99
Cholesterol 162.4 ± 37.0 157.1 ± 32.0 >0.99 163.4 ± 39.0 156.4 ± 35.0 0.81 170.1 ± 39.0 162.7 ± 39.0 0.18 175.8 ± 42.0 163.8 ± 41.0 0.34
LDL 98.4 ± 32.0 94.0 ± 31.0 >0.99 97.7 ± 33.0 92.1 ± 37.0 >0.99 102.7 ± 34.0 98.0 ± 33.0 >0.99 109.7 ± 36.0 98.0 ± 35.0 0.11
HDL 42.0 ± 11.0 42.8 ± 14.0 0.52 42.1 ± 12.0 45.2 ± 16.0 0.48 42.1 ± 12.0 44.6 ± 14.0 0.18 38.3 ± 11.0 41.4 ± 14.0 0.34
Cholesterol/
HDL Ratio
4.1 ± 1.3 4.0 ± 1.4 0.13 4.2 ± 1.4 3.9 ± 1.5 0.05 4.3 ± 1.4 3.9 ± 1.4 0.09 4.8 ± 1.5 4.2 ± 1.3 0.11
Triglycerides 110.2 ± 54.0 101.2 ± 58.0 0.13 118.7 ± 55.0 95.4 ± 49.0 0.24 127.1 ± 57.0 100.9 ± 50.0 0.12 139.1 ± 58.0 122.1 ± 63.0 0.11
Glucose 101.8 ± 14.0 100.2 ± 10.0 >0.99 102.4 ± 15.0 105.6 ± 21.0 0.33 104.8 ± 13.0 100.4 ± 12.0 0.11 102.9 ± 13.0 96.0 ± 8.0 0.11
Insulin 16.7 ± 13.4 8.4 ± 5.9 0.001 17.6 ± 14.0 9.0 ± 5.1 0.001 20.9 ± 16.0 9.9 ± 5.7 0.15 27.6 ± 15.0 14.7 ± 8.0 0.29
HOMA-IR 4.4 ± 3.7 2.21 ± 1.8 0.003 4.7 ± 3.9 2.4 ± 1.6 0.002 5.6 ± 4.3 2.6 ± 1.7 0.39 7.4 ± 4.2 3.7 ± 2.4 0.29
 availability of exercise facilities and limited 
Table 2.
Intervention effects at each measurement interval on key risk markers (mean ± standard deviation).
p-Value represents comparison between values at baseline and each time point using sign tests; only those measured at both time points were included in analysis.
HDL = high-density lipoprotein, HOMA-IR = homeostasis model of assessment-insulin resistance, LDL = low-density lipoprotein.Test
6 Months 12 Months 18 Months 24 Months
Baseline Follow-Up p-Value Baseline Follow-Up p-Value Baseline Follow-Up p-Value Baseline Follow-Up p-Value
Rest
67 ± 15 75 ± 14 >0.99 68 ± 17 79 ± 15 0.55 71 ± 19 74 ± 10 0.69 60 ± 9 80 ± 14 >0.99
119 ± 14 116 ± 21 0.36 124 ± 13 112 ± 13 0.02 121 ± 6 117 ± 6 0.45 118 ± 5 122 ± 8 0.26
73 ± 7 72 ± 11 >0.99 77 ± 4 72 ± 7 0.18 77 ± 3 73 ± 5 0.07 77 ± 4 78 ± 6 0.68
2.5 ± 0.6 2.6 ± 0.6 0.50 2.7 ± 0.5 2.8 ± 0.7 0.39 2.8 ± 0.4 3.1 ± 0.4 <0.01 2.6 ± 0.5 2.6 ± 0.8 0.73
3.4 ± 0.9 3.5 ± 0.8 >0.99 3.6 ± 0.9 3.8 ± 0.9 0.55 3.9 ± 0.8 4.4 ± 0.6 0.07 3.6 ± 1.0 3.7 ± 1.0 0.73
Peak Exercise
124 ± 27 122 ± 28 0.63 127 ± 27 129 ± 26 0.77 134 ± 29 128 ± 27 0.73 108 ± 14 128 ± 38 0.69
142 ± 19 146 ± 32 >0.99 150 ± 18 139 ± 31 0.15 147 ± 11 150 ± 37 0.73 141 ± 13 136 ± 34 >0.99
82 ± 7 77 ± 14 0.24 84 ± 7 75 ± 14 0.39 85 ± 8 80 ± 11 0.73 84 ± 8 80 ± 16 >0.99
37 ± 16 29 ± 14 0.63 38 ± 18 29 ± 9 0.15 43 ± 17 35 ± 19 0.07 33 ± 17 33 ± 18 0.69
12.7 ± 6.0 12.8 ± 5.0 >0.99 12.5 ± 4.0 11.6 ± 4.0 >0.99 17.0 ± 8.0 13.4 ± 6.0 0.12 15.6 ± 2.0 17.0 ± 10.0 >0.99
1.20 ± 0.4 1.8 ± 0.3 0.81 1.16 ± 0.3 1.01 ± 0.2 0.34 1.7 ± 0.6 1.4 ± 0.3 >0.99 1.3 ± 0.2 1.3 ± 0.5 0.03
65.6 ± 33.0 60.6 ± 28.0 0.27 72.5 ± 34.0 67.5 ± 27.0 0.45 83.1 ± 37.0 70 ± 26 0.12 60.7 ± 21.0 49.3 ± 26.0 0.003
Physical Activity
32.7 ± 13.0 29.1 ± 13.0 0.19 30.8 ± 9.6 25.2 ± 14.0 0.23 30.5 ± 12.0 28.9 ± 9.0 0.54 30.0 ± 14.0 20.7 ± 8.0 0.20
552 ± 202 483 ± 194 0.16 538 ± 164 433 ± 227 0.17 533 ± 193 505 ± 164 0.53 479 ± 254 318 ± 85 0.31
13.9 ± 10.0 13.0 ± 11.0 0.70 13.8 ± 10.0 14.6 ± 10.0 0.77 12.7 ± 12.0 11.4 ± 12.0 0.51 7.5 ± 5.0 7.6 ± 6.4 0.98
Macronutrient Intake*
1361 ± 646.0 1516 ± 759 0.63 1317 ± 569 1600 ± 837 0.42 1289 ± 656 1474 ± 805 0.75 1229 ± 704 1142 ± 687 >0.99
62.5 ± 27.0 67.7 ± 35.0 >0.99 62.3 ± 25.0 66.9 ± 31.0 0.79 59.4 ± 29.0 63.6 ± 35.0 0.75 62.5 ± 33.0 47.6 ± 30.0 0.06
59.4 ± 30.0 65.5 ± 33.0 >0.99 60.2 ± 30.0 76.0 ± 43.0 0.42 57.2 ± 33.0 64.2 ± 37.0 0.34 63.0 ± 37.0 57.8 ± 36.0 >0.99
155.6 ± 
84.0
173.3 ± 
90.0
0.33 143.2 ± 
67.0
168.5 ± 
88.0
0.42 151.4 ± 
73.0
172.4 ± 
92.0
>0.99 125.4 ± 
67.0
120.3 ± 
73.0
>0.99
19.0 ± 9.0 19.6 ± 9.0 0.63 19.1 ± 8.0 22.0 ± 12.0 0.58 18.9 ± 10.0 19.8 ± 11.0 0.34 21.4 ± 10.0 17.9 ± 10.0 0.62
160.6 ± 
84.0
193.7 ± 
108.0
0.63 163.5 ± 
65.0
191.2 ± 
110.0
0.42 159.2 ± 
70.0
194.8 ± 
116.0
0.75 156.0 ± 
69.0
180.8 ± 
155.0
>0.99
17.5 ± 8.0 18.0 ± 9.0 0.80 16.9 ± 7.0 18.5 ± 8.0 0.79 18.2 ± 7.0 16.6 ± 9.0 0.75 17.3 ± 8.0 11.1 ± 5.0 0.37
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accessibility and transportation to medical care. While 
some, but not all, previous interventions targeting exercise 
capacity [42], weight management [27], or lipid profiles 
[28] have demonstrated CVD risk may be improved in SCI, 
these studies have generally targeted one risk marker and 
were short-term, and little is known regarding multidisci-
plinary risk reduction over longer periods such as 1 to 2   yr. 
The current study was a pilot effort to fill these gaps by 
assessing the efficacy of a 2 yr, evidence-based program of 
multidisciplinary risk reduction in a SCI cohort.
We observed modest changes in several markers of 
CVD risk; in particular, weight reduction and improve-
ments in insulin level, HOMA-IR, and total cholesterol/
HDL ratio (Table 2). While many of the other risk mark-
ers showed tendencies to improve, these changes were 
small and not consistent enough across time or individu-
als to demonstrate statistical or clinically significant 
change. In addition, these observations cannot be directly 
attributed to dietary changes or higher physical activity 
per se, since neither of these improved appreciably, at 
least inasmuch as questionnaire approaches can detect 
such changes. The possibility exists that lifestyle modifi-
cations occurred that we did not measure or that the tools 
we employed were not sensitive enough to detect 
changes. Overall, our findings suggest that standard case-
management approaches to risk reduction that have been 
successful in ambulatory persons achieve only compara-
tively modest success in those with SCI, and alternative, 
perhaps more intensive models are needed to address the 
problem of CVD risk after SCI. It may also be important 
Table 3.
Exercise test responses, physical activity, and macronutrient intake at each measurement interval.
    Heart Rate
    SBP
    DBP
    FEV1 (L)
    FVC (L)
    Heart Rate
    SBP
    DBP
    Heart Rate Reserve
    VO2 (mL/kg/min)
    VO2 (L/min)
    Watts
    Accelerometer 
Counts (×105)
    Kcals/d
    PASIPD 
(MET h/wk)
    Total Calories 
(<2,300)
    Protein (g) (63)
    Fat (g) (<76)
    Carbohydrate (g) 
(287)
    Saturated Fat (g) 
(<25)
    Cholesterol (mg) 
(<300)
    Fiber (g) (20–35)
*Parentheses represent recommended standards based on an average 55 yr old male [39].
p-Value represents comparison between values at baseline and each time point using sign tests; only those measured at both time points were included in analysis.
DBP = diastolic blood pressure, FEV1 = forced expiratory volume in 1 s, FVC = forced vital capacity, Kcals = kilocalories, PASIPD = Physical Activity Scale for 
Individuals with Physical Disabilities, SBP = systolic blood pressure, VO2 = oxygen uptake.1361
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to consider models more conducive to addressing barriers 
to participation unique to individuals with SCI.
There were several encouraging observations regard-
ing CVD risk; the consistent reduction in insulin levels at 
each evaluation is noteworthy. High circulating insulin 
levels are usually a consequence of insulin resistance and 
have been associated with adverse cardiac events inde-
pendent of other CVD risk markers [43]. Hyperinsu-
linemia is also a major factor underlying abnormal lipid 
metabolism in SCI [10]. In persons with SCI, plasma 
insulin levels are higher following glucose tolerance test-
ing compared with ambulatory persons and are elevated 
with higher levels of injury [44]. We observed a roughly 
50 percent reduction in plasma insulin at each visit com-
pared with baseline, which would appear to represent a 
clinically significant change (Table 2). The effects of this 
degree of reduction on long-term CVD risk in persons 
with SCI are unknown but encouraging. Since the clinical 
implications of persistently elevated plasma insulin 
include higher risk for CVD, higher prevalence of virtu-
ally all the major metabolic risk markers, and higher car-
diovascular morbidity [7,10,43–45], efforts to reverse 
these are warranted. We did not observe changes in activ-
ity patterns or exercise capacity, although it should be 
noted that our study was not directed toward exercise 
training per se. Rather, we attempted to optimize func-
tional capabilities, minimize pain, and identify available 
modalities for each participant.
Another notable response was change in body 
weight; there was a consistent 4 lb reduction from base-
line to each visit up to 18 mo. Although the change was 
significant only at 6 mo, the reduction in study numbers 
likely accounts for the lack of significant change at subse-
quent visits. Obesity has long been a concern in persons 
with SCI, not only because of its high prevalence 
[11,19,46], but also because, similar to in ambulatory 
individuals, obesity has been associated with glucose 
intolerance, hyperlipidemia, hypertension, and other 
metabolic abnormalities in those with SCI [7,47]. In an 
intensive intervention program specifically targeting obe-
sity in 16 persons with SCI, Chen et al. reported 7.7 and 
6.4 lb reductions in body weight at 12 and 24 weeks, 
respectively [27]. The modest reduction in weight 
observed in the current study is noteworthy given that our 
sample was borderline obese at the time of recruitment 
(mean BMI 29.9 m/kg2) and by the consistent observation 
that BMI underestimates body fat in SCI [47]. While lon-
gitudinal studies assessing weight gain following SCI are 
lacking, it is well established that there is a general and 
progressive weight gain in the years after injury [48]. 
Thus, although the observed changes in weight were 
small, counteracting the inevitable weight gain (that is, 
the absence of a gain in weight) in persons with SCI 
through dietary counseling may have long-term benefits 
for metabolic risk.
The dropout rate in our study is notable; only 
40   percent of the participants remained in the study at 
the end of 2 yr. While this was not unexpected in an 
elderly population with SCI, it underscores another of the 
challenges associated with risk intervention in these indi-
viduals. Not surprisingly, medical issues were the most 
common reason for dropping out. These medical issues 
included two deaths, pressure sores, orthopedic prob-
lems, and uncontrolled dyslipidemia. All of the other rea-
sons for dropping out cited by participants were largely 
practical (time commitment, travel issues, scheduling 
conflicts, and inability or unwillingness to comply) and 
are no doubt accentuated by the presence of SCI. The 
adherence rate we observed is typical of other interven-
tion studies in individuals with SCI, in which the major-
ity of dropouts were due to illness or transportation 
difficulties [49]. Future efforts in this area need to con-
sider the low adherence rate and thus modifications to 
study design which accommodate the realities of this 
condition [50].
Our study was limited by the relatively low adher-
ence rate, a common problem in trials of persons with 
SCI [50]. We did not have a control group with which to 
compare and therefore do not have information on how 
these risk markers respond to usual care. The possibility 
of type I error is a concern given the many comparisons 
performed. We did not measure indices of body dimen-
sions other than BMI; it is recognized that BMI does not 
adequately capture the health effects of obesity and that 
BMI underestimates body fat in SCI [47]. In addition, 
accelerometry devices have been validated in ambulatory 
subjects using lower-limb exercise, and little is known 
regarding their application to upper-limb activity in SCI. 
Finally, our study included only males and thus may not 
apply to females.
CONCLUSIONS
Modest but significant changes in CVD risk can be 
achieved by a multidisciplinary risk reduction program in 1362
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persons with SCI. Such programs present more chal-
lenges than those in ambulatory subjects, and achieving 
the goals recommended in recent consensus reports 
focusing on SCI [17] may require novel or creative 
approaches and/or more intensive risk intervention in 
order to effectively reduce CVD risk in this population.
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